DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹15,937 Cr | ₹14,863 Cr | ₹14,619 Cr | ₹11,387 Cr | ₹9,425 Cr |
What is the latest Total Liabilities ratio of DIVIS LABORATORIES ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹15,937 Cr |
Mar2023 | ₹14,863 Cr |
Mar2022 | ₹14,619 Cr |
Mar2021 | ₹11,387 Cr |
Mar2020 | ₹9,425 Cr |
How is Total Liabilities of DIVIS LABORATORIES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹15,937 Cr | 7.23 | |
Mar2023 | ₹14,863 Cr | 1.67 | |
Mar2022 | ₹14,619 Cr | 28.39 | |
Mar2021 | ₹11,387 Cr | 20.82 | |
Mar2020 | ₹9,425 Cr | - |
Compare Total Liabilities of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹154,957.7 Cr | -1.6% | -1.3% | 61.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,003.0 Cr | -1.6% | -4.6% | 14.7% | Stock Analytics | |
CIPLA | ₹117,835.0 Cr | 0.1% | 1.2% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,784.6 Cr | -2.1% | -8.7% | -2.3% | Stock Analytics | |
MANKIND PHARMA | ₹98,888.9 Cr | -4.4% | -7.8% | 13.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹90,722.1 Cr | -6.5% | -9.3% | 8.6% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -1.6% |
-1.3% |
61.6% |
SENSEX | -2.5% |
-1.4% |
6.1% |
You may also like the below Video Courses